The dawn of a new era of targeted therapies for heart failure with preserved ejection fraction (HFpEF)

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Access to Document

@article{6314375caf9b4e028a59de3462c04653,

title = "The dawn of a new era of targeted therapies for heart failure with preserved ejection fraction (HFpEF)",

author = "Kenji Harada and Kazuomi Kario",

year = "2022",

month = jan,

doi = "10.1038/s41440-021-00799-8",

language = "English",

volume = "45",

pages = "164--166",

journal = "Hypertension Research",

issn = "0916-9636",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - The dawn of a new era of targeted therapies for heart failure with preserved ejection fraction (HFpEF)

AU - Harada, Kenji

AU - Kario, Kazuomi

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85120811416

U2 - 10.1038/s41440-021-00799-8

DO - 10.1038/s41440-021-00799-8

M3 - Comment/debate

C2 - 34819620

AN - SCOPUS:85120811416

SN - 0916-9636

VL - 45

SP - 164

EP - 166

JO - Hypertension Research

JF - Hypertension Research

IS - 1

ER -